Jim Cramer on Bristol-Myers Squibb. Co (NYSE:BMY): They Should Have Known Better

We recently published a list of Jim Cramer Discusses These 11 Stocks & Reveals Why Tech Stocks Are Down. In this article, we are going to take a look at where Bristol-Myers Squibb. Co (NYSE:BMY) stands against other stocks that Jim Cramer discussed.

In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer discussed his takeaways from last week’s GTC conference. The event saw Wall Street’s top AI GPU firm unveil its plans for enabling a robot revolution among others. Commenting on his experience, Cramer speculated that he would have understood the AI wave much better had he had an education in engineering instead of in the liberal arts:

“It was a week of intimidation. Because I’m a liberal arts person. . . .it has its advantages, I mean we’ve read Shakespeare, studied the Bible. . .but I had to have everything explained to me in order to be able to be in the room. But once it was explained to me, it was very clear that the bulls are right about AI. The bulls are right about the money it’s going to take and the speed it’s going to take. This is about need for speed now. And it’s a war among Grok and ChatGPT.”

While the conference came with big announcements, its impact on the stock market was negligible. March has been a tough month for stocks, with technology companies particularly failing to recover from a selloff that wiped $4 trillion in market value from the flagship S&P index over its post-election high. Cramer explained why tech stocks haven’t performed well. According to him:

“One of the reasons why the tech stocks have gotten hit is almost everyone’s convinced that if you import anything, there’s going to be 20% tax or 25% tax. So therefore, all numbers have to come down. If you could get a reprieve on that, then the multiple expansion on just regular, garden variety tech would be extraordinary. You’d have to put your money on that. It could lead over to Mag 7, yes. I think our great friend Mike Wilson, with his weekly warmup of Mag 7, I think it was a significant piece. And a lot of it has to do with this notion that these stocks have been made cheap, by both, by bonds, I think they’ve been made cheap by tariffs. So you would revert to them, rather than the lower quality stocks that make up the rest of the S&P 500 equal weight. I think that this is important David, because you know we’ve been taken up by companies that neither you nor I think are great companies. But they’re just, companies. Nothing special.”

Our Methodology

To make our list of the stocks that Jim Cramer talked about, we listed down the stocks he mentioned during CNBC’s Squawk on the Street aired on March 24th.

For these stocks, we also mentioned the number of hedge fund investors. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

Bristol-Myers Squibb. Co (NYSE:BMY)

Number of Hedge Fund Holders In Q4 2024: 88

Bristol-Myers Squibb. Co (NYSE:BMY) is one of Cramer’s top pharmaceutical stocks. While his favorite is weight loss drug maker Eli Lilly, the host is a fan of the firm’s schizophrenia drug. In his previous comments about Bristol-Myers Squibb. Co (NYSE:BMY), Cramer has called the firm’s COBENFY schizophrenia drug a “silver bullet” for the disease. This time around, he commented on the firm along the lines of ill-advised business spinoffs:

“These are ill-advised. Some banker came in and said, you want a higher multiple? Get rid of the stuff that does, just is kind of, you know, doesn’t grow, grows 7%, and just blow out with your 18% drug. Well you know, that’s fine. Until you have a hole in your pipeline. And then what do you do? Look at Bristol-Myersss, okay, that stock has a PE of 8 because it doesn’t have this kind of. . .I just say that you know these companies do this stuff David, and then when you really drill down on it, they just say, well Jim, you’ll a generalist, what do you know?”

Overall, BMY ranks 3rd on our list of stocks that Jim Cramer discusses. While we acknowledge the potential of BMY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than BMY but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires

Disclosure: None. This article is originally published at Insider Monkey.